Targeting CGRP: Emerging Solutions in Migraine
|Targeting CGRP: Emerging Solutions in Migraine|
CME, CPE, CNE
Merle L. Diamond, MD; Mark W. Green, MD, FAAN
|Release Date: December 28, 2016|
Expiration Date: December 28, 2017
Participate in this interactive and forward-thinking activity to make sure you are prepared and “in the know” on the current and ongoing clinical trials targeting calcitonin gene-related peptide (CGRP) and their impact on the current unmet need in the treatment options for preventive treatment in migraine.
Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Teva Pharmaceuticals
|View Only, CE ExpiredView Only, No Credit|